Novel mutations associated with carnitine palmitoyltransferase II deficiency
- PMID: 10090476
- DOI: 10.1002/(SICI)1098-1004(1999)13:3<210::AID-HUMU5>3.0.CO;2-0
Novel mutations associated with carnitine palmitoyltransferase II deficiency
Abstract
The most common form of carnitine palmitoyltransferase II (CPT II) deficiency occurs in adults and is characterized by muscle pain, stiffness, and myoglobinuria, triggered by exercise, fasting, or other metabolic stress. This study reports the molecular heterogeneity of CPT2 mutations and their biochemical consequences among a series of 59 individuals who were suspected of having CPT II deficiency based on the decreased CPT activity observed in muscle or leukocytes samples, clinical findings, or referral for mutation analysis from other laboratories. Only 19 subjects were considered to be at particularly high risk of CPT II deficiency based on review of their clinical symptoms and residual CPT activity. The samples were initially screened for 11 mutations with allele-specific oligonucleotides (ASO). Extensive sequence analysis was subsequently performed on 14 samples which either had a CPT2 mutation detected by ASO screening or the residual CPT activity was below that observed in ASO positive samples. Three known (P50H, S113L, and F448L) and three novel mutations were identified among 13 individuals in this study. A single nucleotide polymorphism was also identified 11 bp distal to the CPT2 polyadenylation site that will be useful for linkage analysis. Two of the new mutations were single nucleotide missense mutations, R503C and G549D, that occurred in highly conserved regions of the CPT isoforms, and the third was a frameshift mutation, 413 delAG, caused by a 2-bp deletion upstream of a previously identified missense mutation, F448L. The 413 delAG mutation was the second most common mutation identified in our study (20% of mutant alleles) and all individuals with the mutation were of Ashkenazi Jewish ancestry suggesting a defined ethnic origin for the mutation. Despite rigorous mutation analysis, six of 13 individuals identified with CPT2 mutations remained as heterozygotes. We propose that heterozygosity for certain CPT2 mutations, S113L and R503C, is sufficient to render individuals at risk of clinical symptoms.
Similar articles
-
Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.Hum Mutat. 2000 Jun;15(6):579-80. doi: 10.1002/1098-1004(200006)15:6<579::AID-HUMU14>3.0.CO;2-H. Hum Mutat. 2000. PMID: 10862092
-
A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.Mol Genet Metab. 2000 Jun;70(2):134-41. doi: 10.1006/mgme.2000.3009. Mol Genet Metab. 2000. PMID: 10873395
-
Carnitine palmitoyltransferase deficiencies.Mol Genet Metab. 1999 Dec;68(4):424-40. doi: 10.1006/mgme.1999.2938. Mol Genet Metab. 1999. PMID: 10607472 Review.
-
Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.Arch Neurol. 2005 Jan;62(1):37-41. doi: 10.1001/archneur.62.1.37. Arch Neurol. 2005. PMID: 15642848
-
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520. doi: 10.1016/j.mam.2004.06.004. Mol Aspects Med. 2004. PMID: 15363638 Review.
Cited by
-
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.World J Gastroenterol. 2023 Mar 28;29(12):1765-1778. doi: 10.3748/wjg.v29.i12.1765. World J Gastroenterol. 2023. PMID: 37032731 Free PMC article. Review.
-
Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.J Inherit Metab Dis. 2003;26(6):543-57. doi: 10.1023/a:1025947930752. J Inherit Metab Dis. 2003. PMID: 14605500
-
The clinical laboratory evaluation of the patient with noninflammatory myopathy.Curr Rheumatol Rep. 2001 Aug;3(4):310-6. doi: 10.1007/s11926-001-0035-0. Curr Rheumatol Rep. 2001. PMID: 11470050 Review.
-
Increased missense mutation burden of Fatty Acid metabolism related genes in nunavik inuit population.PLoS One. 2015 May 26;10(5):e0128255. doi: 10.1371/journal.pone.0128255. eCollection 2015. PLoS One. 2015. PMID: 26010953 Free PMC article. Clinical Trial.
-
The diagnostic yield of exome sequencing in liver diseases from a curated gene panel.Sci Rep. 2023 Dec 6;13(1):21540. doi: 10.1038/s41598-023-42202-1. Sci Rep. 2023. PMID: 38057357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases